<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CPHD</title>
    <link />
    <description>Headlines for Cepheid</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Cepheid Enters Oversold Territory (CPHD)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11938833/1/cepheid-enters-oversold-territory-cphd.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 31 May 2013 16:32:00 GMT</pubDate>
    </item>
    <item>
      <title>CPHD Makes Notable Cross Below Critical Moving Average</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11938571/1/cphd-makes-notable-cross-below-critical-moving-average.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 31 May 2013 12:11:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Assumes Coverage on Cepheid, Downgrades to Hold on Valuation</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3637451/update-jefferies-assumes-coverage-on-cepheid-downgrades-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 31 May 2013 10:55:23 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Downgrades Cepheid to Hold on Persistent Volatility</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/05/3637066/update-jefferies-downgrades-cepheid-to-hold-on-persisten.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 31 May 2013 09:29:43 GMT</pubDate>
    </item>
    <item>
      <title>Neutral Rating Restated for Cepheid - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99244/neutral-rating-restated-for-cepheid.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 13 May 2013 14:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Huge Earnings Miss By AMED, Guides Low - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98380/huge-earnings-miss-by-amed-guides-low.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 01 May 2013 14:38:01 GMT</pubDate>
    </item>
    <item>
      <title>ResMed's Earnings Beat; Revs Lag - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98166/resmeds-earnings-beat-revs-lag.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 29 Apr 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CEO Sells Highlight: SeaCube, Hasbro, Cepheid, Honeywell</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/217642/weekly-ceo-sells-highlight-seacube-hasbro-cepheid-honeywell.aspx?source=itxwebtxt0000015</link>
      <author>GuruFocus</author>
      <pubDate>Sun, 28 Apr 2013 23:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Weekly CEO Sells Highlight: SeaCube, Hasbro, Cepheid, Honeywell</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/weekly-ceo-sells-highlight-seacube-hasbro-cepheid-honeywell-cm241357.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Sun, 28 Apr 2013 21:59:59 GMT</pubDate>
    </item>
    <item>
      <title>Covidien Expands Shiley Offerings - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97485/covidien-expands-shiley-offerings.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 19 Apr 2013 14:50:01 GMT</pubDate>
    </item>
    <item>
      <title>FDA Nod for Luminex Offering - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97479/fda-nod-for-luminex-offering.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 19 Apr 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130419-000392&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 19 Apr 2013 06:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Cepheid Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1353371-cepheid-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 18 Apr 2013 21:20:05 GMT</pubDate>
    </item>
    <item>
      <title>New Patent for Biolase - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97378/new-patent-for-biolase.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 18 Apr 2013 15:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Myriad Downgraded to Neutral - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97370/myriad-downgraded-to-neutral.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 18 Apr 2013 15:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Initiations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/04/3507609/benzingas-top-initiations.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 18 Apr 2013 08:21:21 GMT</pubDate>
    </item>
    <item>
      <title>More Backing for HOLX Tomosynthesis - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97278/more-backing-for-holx-tomosynthesis.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 17 Apr 2013 15:02:01 GMT</pubDate>
    </item>
    <item>
      <title>Varian Applies Latest Vitesse - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97272/varian-applies-latest-vitesse.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 17 Apr 2013 14:42:01 GMT</pubDate>
    </item>
    <item>
      <title>Covance Augments Singapore Facility - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97159/covance-augments-singapore-facility.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 16 Apr 2013 17:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Biolase Gets FDA Nod for EPIC 10S - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97085/biolase-gets-fda-nod-for-epic-10s.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 16:20:01 GMT</pubDate>
    </item>
  </channel>
</rss>
